The comparative efficacy of renin-angiotensin system blockers in schistosomal hepatic fibrosis. [electronic resource]
- Experimental parasitology Aug 2018
- 9-18 p. digital
Publication Type: Journal Article
1090-2449
10.1016/j.exppara.2018.05.004 doi
Amides--pharmacology Angiotensin II Type 1 Receptor Blockers--pharmacology Angiotensin-Converting Enzyme Inhibitors--pharmacology Animals Antihypertensive Agents--pharmacology Bradykinin--pharmacology Fumarates--pharmacology Lisinopril--pharmacology Liver--drug effects Liver Cirrhosis--drug therapy Losartan--pharmacology Male Mice Mice, Inbred BALB C Nitric Oxide Synthase Type III--drug effects Proto-Oncogene Mas Proto-Oncogene Proteins--drug effects Receptors, G-Protein-Coupled--drug effects Renin--drug effects Renin-Angiotensin System--drug effects Schistosomiasis mansoni--complications Tissue Inhibitor of Metalloproteinase-1--drug effects Transforming Growth Factor beta1--drug effects Vasodilator Agents--pharmacology p38 Mitogen-Activated Protein Kinases--drug effects